• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 277/32 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 277/32

Total number of patents in this class: 140

10-year publication summary

13
13
10
7
7
3
5
8
8
1
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
BASF SE
21303
11
Sumitomo Chemical Company, Limited
8996
6
Syngenta Participations AG
1527
4
Georgia Tech Research Corporation
2942
4
Abbvie Inc.
1836
3
The Board of Trustees of the University of Illinois
2750
3
Mitsui Chemicals Crop & Life Solutions,Inc.
174
3
AstraZeneca AB
2818
2
Syngenta Crop Protection AG
6699
2
Allergan, Inc.
2169
2
Bayer Cropscience AG
1846
2
Wisconsin Alumni Research Foundation
3887
2
Takeda Pharmaceutical Company Limited
2715
2
Arkema Inc.
1060
2
Beiersdorf AG
3101
2
East China University of Science and Technology
552
2
FMC Corporation
807
2
Gifu University
123
2
Korea Research Institute of Chemical Technology
1469
2
Meiji Seika Pharma Co., Ltd.
256
2
Other owners 80